Program: East Asian LCVL 2023 - Korean Language

Article and Video CATEGORIES

Cancer Journey

ABOUT

Dr. Chul Kim is an Associate Professor at Georgetown University focusing on thoracic oncology. His goal as a thoracic medical oncologist is to introduce innovative cancer therapies into clinical practice, and he is devoted to formulating clinical trials aimed at promoting personalized cancer treatments.

Program: East Asian LCVL 2023 - Korean Language

AlexandraGBeneke

Tue, 08/13/2024 - 08:36

English: Oncologists speak on topics in lung cancer, including risk factors, targeted therapy options, and the importance of genetic testing.

Korean: 종양학자들은 위험 요인, 표적 치료 옵션, 유전자 검사의 중요성 등 폐암 관련 주제에 대해 강연합니다.

Author

Chul Kim, MD - Guest Faculty

In this video series, Dr. Chul Kim translates discussions on lung cancer in Korean. Videos include information on SCLC and NSCLC including statistics and risk factors.

To watch the full playlist click here.

Video Language

Mandarin

Please feel free to offer comments and raise questions in our
discussion forums.

Join The conversation

Next Previous link

Previous Post Next Post

Article

The article describes the AVO treatment, a combination therapy for Chronic Lymphocytic Leukemia (CLL), particularly for high-risk patients. CLL is a slow-growing cancer where abnormal white blood cells accumulate. "High-risk" CLL refers to cases with specific genetic changes (e.g., in TP53) that make the disease harder to treat.